The Cell Game: Sam Waksal's Fast Money and False Promises–And the Fate of Imclone's Cancer Drug by Alex Prud'homme
English | Feb. 2004 | ISBN: 0060555564 | 412 Pages | PDF | 2 MB
At 9:01 A.M. on December 27, 2001, an unemployed, 27-year-old actress named Aliza Waksal sold 39,472 shares of a small Manhattan biotech firm called ImClone Systems, Inc. It netted her some $2.5 million. At 9:41 A.M., Jack Waksal, Aliza’s 80-year-old grandfather, sold approximately 111,336 shares of ImClone, for about $7 million. Both trades had been allegedly prompted by Sam Waksal, who was Aliza’s father and Jack’s son; he was also the cofounder and CEO of ImClone.